PMID- 23973300 OWN - NLM STAT- MEDLINE DCOM- 20140508 LR - 20131007 IS - 1872-7972 (Electronic) IS - 0304-3940 (Linking) VI - 553 DP - 2013 Oct 11 TI - MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model. PG - 153-8 LID - S0304-3940(13)00720-9 [pii] LID - 10.1016/j.neulet.2013.08.001 [doi] AB - MicroRNAs (miRs) are endogenous small RNAs that regulate gene expression at the post-transcriptional level by mediating mRNA degradation or transcriptional inhibition. MiRs were implicated in the pathogenesis of numerous neurodegenerative diseases, including Parkinson's disease (PD). In this study we analyzed the possible role of miRs in the neurodegenerative process in a spontaneous autosomal recessive rat model for neurodegeneration developed in our laboratory. To investigate the role of miRs in the etiology of PD, we conducted miR expression profiling using microarrays. We found 20 miRs that are deregulated in affected rats and many of these are implicated in neurodegenerative disease, including PD. In this study we were particularly interested in the expression of miR-132, a miR that has been reported to be highly expressed in neurons, and to have a potential role in neurodegenerative diseases. We found a significant increase in miR-132 in affected rats by microarray and the result was confirmed by qPCR. Next we analyzed one of the known downstream targets of miR-132, nuclear receptor related 1 protein (Nurr1), which is essential in neurogenesis of midbrain dopaminergic neurons. Western blot analysis and immunohistochemistry revealed a significant decrease in Nurr1 protein expression in the mesencephalic neurons. Finally, we found a significant decrease in both serum and mesencephalon brain tissue of brain-derived neurotrophic factor (BDNF), which is known to be a direct target of Nurr1. Taken together, our findings suggest that miR-132 can regulate Nurr1 levels and might influence the development and function of midbrain dopaminergic neurons. CI - Copyright (c) 2013 Elsevier Ireland Ltd. All rights reserved. FAU - Lungu, Gina AU - Lungu G AD - Department of Veterinary Pathobiology, Texas A&M University, College Station, TX 77843, USA. FAU - Stoica, George AU - Stoica G FAU - Ambrus, Andy AU - Ambrus A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130821 PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (MIRN132 microRNA, rat) RN - 0 (MicroRNAs) RN - 0 (Nr4a2 protein, rat) RN - 0 (Nuclear Receptor Subfamily 4, Group A, Member 2) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/metabolism MH - Disease Models, Animal MH - Gene Expression Profiling MH - Gene Expression Regulation MH - Mesencephalon/metabolism MH - MicroRNAs/*metabolism MH - Nerve Degeneration/*metabolism MH - Nuclear Receptor Subfamily 4, Group A, Member 2/metabolism MH - Rats OTO - NOTNLM OT - BDNF OT - MicroRNA OT - MicroRNA-132 OT - Neurodegeneration OT - Nurr1 OT - Rat model EDAT- 2013/08/27 06:00 MHDA- 2014/05/09 06:00 CRDT- 2013/08/27 06:00 PHST- 2013/05/20 00:00 [received] PHST- 2013/07/19 00:00 [revised] PHST- 2013/08/02 00:00 [accepted] PHST- 2013/08/27 06:00 [entrez] PHST- 2013/08/27 06:00 [pubmed] PHST- 2014/05/09 06:00 [medline] AID - S0304-3940(13)00720-9 [pii] AID - 10.1016/j.neulet.2013.08.001 [doi] PST - ppublish SO - Neurosci Lett. 2013 Oct 11;553:153-8. doi: 10.1016/j.neulet.2013.08.001. Epub 2013 Aug 21.